Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: A survey of 796 outpatients in Japan

Journal of Anxiety Disorders

Volumn 23, Issue 4, 2009, Pages 477-481

  Uchida, Hiroyuki ^a,b,c   Suzuki, Takefumi ^a,d   Mamo, David C ^b,c   Mulsant, Benoit H ^b,c   Kikuchi, Toshiaki ^a,e   Takeuchi, Hiroyoshi ^a,f   Tomita, Masayuki ^a,e   Watanabe, Koichiro ^a,e   Yagi, Gohei ^a,g   Kashima, Haruo ^a  

^a KEIO UNIVERSITY   (Japan)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Inokashira Hospital   (Japan)

^e Sakuragaoka Memorial Hospital   (Japan)

^f Ohizumi Hospital   (Japan)

^g Suisei Healing Center   (Japan)

Author keywords

Aging; Antidepressant; Anxiety disorder; Benzodiazepine; Elderly; Neurotic disorder

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; FLUVOXAMINE; IMIPRAMINE; MILNACIPRAN; PAROXETINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGING; ANXIETY DISORDER; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DRUG SAFETY; DRUG USE; ELDERLY CARE; FEMALE; HEALTH SURVEY; HUMAN; JAPAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEUROSIS; OUTPATIENT; OUTPATIENT CARE; PRESCRIPTION; SCHOOL CHILD; STATISTICAL ANALYSIS; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; YOUNG ADULT;

EID: 62649158905     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.janxdis.2008.10.003     Document Type: Article

References (37)

1. Angus W.R., and Romney D.M. The effect of diazepam on patients' memory. Journal of Clinical Psychopharmacology 4 (1984) 203-206
2. Balestrieri M., Marcon G., Samani F., Marini M., Sessa E., Gelatti U., et al. Mental disorders associated with benzodiazepine use among older primary care attenders-a regional survey. Social Psychiatry and Psychiatric Epidemiology 40 (2005) 308-315
3. Ballenger J.C., Davidson J.R., Lecrubier Y., Nutt D.J., Borkovec T.D., Rickels K., et al. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. The Journal of Clinical Psychiatry 62 Suppl. 11 (2001) 53-58
4. Benitez C.I., Smith K., Vasile R.G., Rende R., Edelen M.O., and Keller M.B. Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study. The American Journal of Geriatric Psychiatry 16 (2008) 5-13
5. Bergmann, K. (1971). The neuroses of old age, in recent developments in psychogeriatrics: a symposium. In: D. W. K. Kay & A. Walk (Eds.), British Journal of Psychiatry Special Publication (Vol. 6). Kent, England: Headley Brothers.
6. Bourin M. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review. Human Psychopharmacology 18 (2003) 185-190
7. Bruce T.J., Spiegel D.A., Gregg S.F., and Nuzzarello A. Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. The American Journal of Psychiatry 152 (1995) 1156-1160
8. Butler R., Collins E., Katona C., and Orrell M. How do general practitioners select antidepressants for depressed elderly people?. International Journal of Geriatric Psychiatry 15 (2000) 610-613
9. Cheng J.S., Huang W.F., Lin K.M., and Shih Y.T. Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan. International Journal of Geriatric Psychiatry 23 (2008) 618-624
10. Cook J.M., Biyanova T., Thompson R., and Coyne J.C. Older primary care patients' willingness to consider discontinuation of chronic benzodiazepines. General Hospital Psychiatry 29 (2007) 396-401
11. Cook J.M., Marshall R., Masci C., and Coyne J.C. Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study. Journal of General Internal Medicine 22 (2007) 303-307
12. Fick D.M., Cooper J.W., Wade W.E., Waller J.L., Maclean J.R., and Beers M.H. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Archives of Internal Medicine 163 (2003) 2716-2724
13. Flint A.J. Epidemiology and comorbidity of anxiety disorders in the elderly. The American Journal of Psychiatry 151 (1994) 640-649
14. Goisman R.M., Rogers M.P., Steketee G.S., Warshaw M.G., Cuneo P., and Keller M.B. Utilization of behavioral methods in a multicenter anxiety disorders study. The Journal of Clinical Psychiatry 54 (1993) 213-218
15. Goisman R.M., Warshaw M.G., and Keller M.B. Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996. The American Journal of Psychiatry 156 (1999) 1819-1821
16. Inagaki A., Inada T., and Fujii Y. Dose equivalents of psychotropic drugs Tokyo (1999), Seiwa Press [not available in English]
17. Katz I.R., Reynolds III C.F., Alexopoulos G.S., and Hackett D. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials. Journal of the American Geriatrics Society 50 (2002) 18-25
18. Kirby M., Denihan A., Bruce I., Radic A., Coakley D., and Lawlor B.A. Benzodiazepine use among the elderly in the community. International Journal of Geriatric Psychiatry 14 (1999) 280-284
19. Koran L.M., Hanna G.L., Hollander E., Nestadt G., and Simpson H.B. Practice guideline for the treatment of patients with obsessive-compulsive disorder. The American Journal of Psychiatry 164 7 Suppl. (2007) 5-53
20. Lenze E.J., Pollock B.G., Shear M.K., Mulsant B.H., Bharucha A., and Reynolds III C.F. Treatment considerations for anxiety in the elderly. CNS Spectrums 8 12 Suppl. 3 (2003) 6-13
21. Linden M., Bar T., and Helmchen H. Prevalence and appropriateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE). International Psychogeriatrics 16 (2004) 461-480
22. Nurmi-Luthje I., Kaukonen J.P., Luthje P., Naboulsi H., Tanninen S., Kataja M., et al. Use of benzodiazepines and benzodiazepine-related drugs among 223 patients with an acute hip fracture in Finland: comparison of benzodiazepine findings in medical records and laboratory assays. Drugs Aging 23 (2006) 27-37
23. Otto M.W., Pollack M.H., Sachs G.S., Reiter S.R., Meltzer-Brody S., and Rosenbaum J.F. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. The American Journal of Psychiatry 150 (1993) 1485-1490
24. Rijcken C.A., Monster T.B., Brouwers J.R., and de Jong-van den Berg L.T. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?. Journal of Clinical Psychopharmacology 23 (2003) 657-659
25. Rochon P.A., Lane C.J., Bronskill S.E., Sykora K., Anderson G.M., Mamdani M.M., et al. Potentially inappropriate prescribing in Canada relative to the US. Drugs Aging 21 (2004) 939-947
26. Schuurmans J., Comijs H.C., Beekman A.T., de Beurs E., Deeg D.J., Emmelkamp P.M., et al. The outcome of anxiety disorders in older people at 6-year follow-up: results from the Longitudinal Aging Study Amsterdam. Acta Psychiatrica Scandinavica 111 (2005) 420-428
27. Simon G.E., and Ludman E.J. Outcome of new benzodiazepine prescriptions to older adults in primary care. General Hospital Psychiatry 28 (2006) 374-378
28. Solai L.K., Mulsant B.H., and Pollock B.G. Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drugs Aging 18 (2001) 355-368
29. Spiegel D.A. Psychological strategies for discontinuing benzodiazepine treatment. Journal of Clinical Psychopharmacology 19 6 Suppl. 2 (1999) 17S-22S
30. Spiegel D.A., Bruce T.J., Gregg S.F., and Nuzzarello A. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?. The American Journal of Psychiatry 151 (1994) 876-881
31. Swift C.G., Swift M.R., Hamley J., Stevenson I.H., and Crooks J. Side-effect 'tolerance' in elderly long-term recipients of benzodiazepine hypnotics. Age Ageing 13 (1984) 335-343
32. Uchida, H., Mamo, D. C., Mulsant, B. H., Pollock, B. G., & Kapur, S. (in press). Why do the elderly need lower doses of antipsychotics? - evidence and mechanisms. The Journal of Clinical Psychiatry.
33. Uchida H., Suzuki T., Mamo D.C., Mulsant B.H., Tanabe A., Inagaki A., et al. Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in Japan. The American Journal of Geriatric Psychiatry 16 (2008) 584-593
34. Valenstein M., Taylor K.K., Austin K., Kales H.C., McCarthy J.F., and Blow F.C. Benzodiazepine use among depressed patients treated in mental health settings. The American Journal of Psychiatry 161 (2004) 654-661
35. Veronese A., Garatti M., Cipriani A., and Barbui C. Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation. European Journal of Clinical Pharmacology 63 (2007) 867-873
36. Windle A., Elliot E., Duszynski K., and Moore V. Benzodiazepine prescribing in elderly Australian general practice patients. Australian and New Zealand Journal of Public Health 31 (2007) 379-381
37. World Health Organization. (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.